| 23.04.2024 14:26 | WTB, ROR, SAFE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.04.2024 09:43 | AVCT | Block Listing Application to AIM | RNS |
| 23.04.2024 07:00 | AVCT | Notice of Results | RNS |
| 22.04.2024 17:51 | 1SN, AVCT, ZEN | TRADING UPDATES: First Tin updates Tellerhauser estimates | Alliance |
| 22.04.2024 12:14 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 09.04.2024 17:00 | AVCT | Avacta Reports Data at the AACR Annual Meeting | RNS |
| 08.04.2024 07:00 | AVCT | AVA6000 Abstract Release by AACR | RNS |
| 28.03.2024 16:00 | AVCT | Investor Webinar | Reach |
| 21.03.2024 10:37 | AVCT | Avacta doses third patient in drug conjugate trial for tumour tissue | Alliance |
| 21.03.2024 07:00 | AVCT | Update on AVA6000 Phase 1a Clinical Trial Progress | RNS |
| 18.03.2024 14:31 | AVCT | IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares | Alliance |
| 18.03.2024 13:26 | AVCT | Result of General Meeting | RNS |
| 06.03.2024 07:00 | AVCT | Avacta Announces AVA6000 Poster at AACR | RNS |
| 05.03.2024 17:09 | HARL, ARB, AVCT | EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract | Alliance |
| 05.03.2024 07:00 | AVCT | Result of REX Retail Offer | RNS |
| 29.02.2024 12:18 | AVCT | Avacta increases placing size to GBP26 million thanks to strong demand | Alliance |
| 29.02.2024 10:27 | AVCT, BCE, THR | AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise | Alliance |
| 29.02.2024 07:00 | AVCT | Result of Placing | RNS |
| 28.02.2024 20:31 | CGO, BCE, DSM | TRADING UPDATES: Avacta plans fundraise to fund clinical development | Alliance |
| 28.02.2024 16:42 | AVCT | Proposed REX Retail Offer | RNS |
| 28.02.2024 16:41 | AVCT | Proposed Fundraise to progress Therapeutics | RNS |
| 16.02.2024 07:00 | AVCT | Share Incentive Plan/Issue of Equity | RNS |
| 22.01.2024 10:51 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 19.01.2024 09:11 | AVCT | IN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise" | Alliance |
| 19.01.2024 07:00 | AVCT | Appointment of Christina Coughlin | RNS |
| 19.12.2023 09:57 | AVCT | IN BRIEF: Avacta taps biopharma veteran as Therapeutics business chief | Alliance |
| 19.12.2023 07:00 | AVCT | Appointment of Chief Business Officer | RNS |
| 13.12.2023 11:49 | AVCT | Avacta says study shows cancer treatment AVA6000 working as planned | Alliance |
| 13.12.2023 07:00 | AVCT | ALS-6000-101 Phase 1a Study Data | RNS |
| 04.12.2023 07:00 | AVCT | Shareholder update to review AVA6000 Phase 1a data | RNS |
| 27.10.2023 07:00 | AVCT | Block Listing Six Monthly Return | RNS |
| 23.10.2023 13:30 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 18.10.2023 13:00 | AVCT | Block Listing Application to AIM | RNS |
| 29.09.2023 13:30 | AVCT | Director/PDMR Shareholding | RNS |
| 28.09.2023 11:08 | AVCT | IN BRIEF: Avacta loss widens on cost rise but clinical tests positive | Alliance |
| 28.09.2023 07:00 | AVCT | Interim Results for the Period Ending 30 June 2023 | RNS |
| 21.09.2023 15:48 | XLM, TRIN, TRLS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.09.2023 14:37 | GENF, ETX, UJO | TRADING UPDATES: Capital inks contract; Lansdowne becomes cash shell | Alliance |
| 20.09.2023 14:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 20.09.2023 07:01 | AVCT | Peel Hunt Appointed as Joint Broker | RNS |
| 20.09.2023 07:00 | AVCT | Appointment Dr.Christina Coughlin as a consultant | RNS |
| 19.09.2023 13:36 | AVCT | Avacta notes "excellent" safety profile for prospective sarcoma drug | Alliance |
| 19.09.2023 07:00 | AVCT | Successful Completion of Sixth Dose Escalation | RNS |
| 06.09.2023 07:00 | AVCT | Notice of Results | RNS |
| 21.07.2023 16:00 | AVCT | IN BRIEF: Avacta Group issues 3.8 million shares to make repayment | Alliance |
| 21.07.2023 15:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 28.06.2023 11:00 | AVCT | Result of Annual General Meeting | RNS |
| 28.06.2023 07:00 | AVCT | Annual General Meeting and Shareholder Event | RNS |
| 21.06.2023 15:43 | ZED, WSG, W7L | UK shareholder meetings calendar - next 7 days | Alliance |
| 21.06.2023 09:58 | AVCT | Avacta says AVA6000 fifth dose escalation results "very favourable" | Alliance |
| 21.06.2023 07:00 | AVCT | Completion of Fifth Dose Escalation in AVA6000 | RNS |
| 19.06.2023 12:43 | AVCT | IN BRIEF: Avacta says no fundraising imminent after market speculation | Alliance |
| 19.06.2023 07:01 | AVCT | Director Appointment | RNS |
| 19.06.2023 07:00 | AVCT | Statement regarding market speculation | RNS |
| 08.06.2023 07:00 | AVCT | AGM and Shareholder Event Detailed Agenda | RNS |
| 05.06.2023 12:06 | AVCT | Avacta sees shares rise on new equity payment for South Korea venture | Alliance |
| 05.06.2023 07:00 | AVCT | Second Milestone in AffyXell Joint Venture | RNS |
| 02.06.2023 07:00 | AVCT | Posting of Annual Report and Notice of AGM | RNS |
| 01.06.2023 10:24 | AVCT | Avacta enhances rapid test portfolio with GBP7.4 million Coris buy | Alliance |
| 01.06.2023 07:00 | AVCT | Avacta acquires Coris Bioconcept | RNS |
| 27.04.2023 14:34 | IPF, TRP, EXR | TRADING UPDATES: Volex wins contract; Engage XR revenue jumps | Alliance |
| 27.04.2023 07:00 | AVCT | Block Listing Six Monthly Return | RNS |
| 27.04.2023 07:00 | AVCT | First Patient Dosed in the US in AVA6000 Phase 1 | RNS |
| 25.04.2023 14:39 | HVO, AVCT, OTV2 | EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout | Alliance |
| 25.04.2023 07:00 | AVCT | Preliminary Results | RNS |
| 21.04.2023 14:49 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 18.04.2023 15:47 | WTB, WPS, TPK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 17.04.2023 07:00 | AVCT | AVA3996 data poster presented at AACR | RNS |
| 06.04.2023 12:14 | AVCT | Avacta opens first two clinical investigator sites in US for AVA6000 | Alliance |
| 06.04.2023 07:00 | AVCT | 1st US Clinical Investigator AVA6000 Sites Opened | RNS |
| 05.04.2023 12:12 | AVCT | Avacta doses first patient in fifth cohort of AVA6000 phase 1 study | Alliance |
| 05.04.2023 07:00 | AVCT | First Patient Dosed in Fifth Cohort of AVA6000 | RNS |
| 03.04.2023 07:00 | AVCT | Notice of Results and Investor Presentation | RNS |
| 27.03.2023 07:00 | AVCT | AVA3996 data poster presentation at AACR | RNS |
| 13.03.2023 12:18 | VRCI, CSFS, SCLP | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
